🔎 Trials Near Me

Home › Coronary Artery Disease › Michigan

Coronary Artery Disease clinical trials in Michigan

13 studies for Coronary Artery Disease are looking for participants at sites in Michigan.

Cities in Michigan

Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

  • Henry Ford Health / St. John Hospital, Detroit
Recruiting
Ages 18 to 90 · All sexes · Updated Sep 30, 2026 · NCT07296744

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

  • UMH-Sparrow Clinical Research Institute, Lansing
  • MyMichigan Medical Center Midland, Midland
  • Healthy Heart Cardiology at Rochester Hills (Advanced Cardiology Associates, Rochester Hills
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565

IVUS CHIP UPP Registry

  • Henry Ford Health System, Detroit
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06625801

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Paragon Health, Inc, Kalamazoo
  • Michigan Kidney Consultants, PC, Pontiac
  • St. Clair Nephrology Research, Roseville
  • and 1 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961

Product Surveillance Registry

  • Ann Arbor
  • Bay City
  • Lansing
  • and 2 more
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276

Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

  • Corewell Health Research Institute, Royal Oak
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Sep 11, 2026 · NCT07048808

Prospective Global Registry for the Study of Chronic Total Occlusion Intervention

  • Henry Ford Medical Center, Detroit
RecruitingObservational study
All ages · All sexes · Updated Aug 19, 2026 · NCT02061436

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

  • Henry Ford Hospital, Detroit
Recruiting
Ages 18 and older · All sexes · Updated Jul 24, 2026 · NCT06779630

Virtue® SAB in the Treatment of Coronary ISR Trial

  • Corewell Health William Beaumont University Hospital, Royal Oak
Recruiting
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT07045194

Prevail Global Study

  • University of Michigan Health System - University Hospital, Ann Arbor
  • Corewell Health, Grand Rapids
  • Saint Joseph Mercy Ann Arbor, Ypsilanti
Recruiting
Ages 18 and older · All sexes · Updated Apr 24, 2026 · NCT06535854

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

  • University of Michigan, Ann Arbor
  • Corewell Health William Beaumont University Hospital, Royal Oak
Recruiting
Ages 18 and older · Women · Updated Apr 1, 2026 · NCT04124120

Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

  • Sparrow Clinical Research Institute, Lansing
  • William Beaumont Hospital, Royal Oak
  • Ascension St. Mary's, Saginaw
  • and 1 more
Recruiting
All ages · All sexes · Updated Jul 24, 2025 · NCT04634240

Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

  • University of Michigan, Ann Arbor
Recruiting
Ages 18 and older · All sexes · Updated Jun 19, 2025 · NCT05701358

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.